BellSouth Announces Plans to Restate Financial Results

Company's second- and third-quarter results to reflect $187 million charge.

Author:: Eileen Kinsella
Publish date:: Dec 3, 1999 7:00 PM EST

BellSouth

(BLS)

said it will restate its second- and third-quarter financial results to include a $187 million, second-quarter charge related to an upgrade in its U.S. wireless network.

A noncash, post-tax charge of about 10 cents a share will be reflected in revised second-quarter 1999 results. Despite the revision, BellSouth said it expects earnings growth for 1999 to be in the 19% to 21% range. The current 15-analyst estimate calls for 1999 earnings of $2.00 a share.

After-Hours Trading

Island ECN, owned by Datek Online, offers trading, mainly in Nasdaq-listed stocks, from 8 a.m. to 8 p.m. EST.

Confused?

TheStreet.com

explains how the rules change when the sun goes down in Investing Basics: Night Owl, a section devoted to after-hours trading.

Patrick M. Fitzgibbons

Mergers, acquisitions and joint ventures

Boston Properties

(BXP) - Get Report

and

Cornerstone Properties

(CPP)

signed a communications deal with

Cypress Communications

, a telecommunications services provider.

A Delaware judge set an April 10 date for a trial to settle the dispute between

Warner-Lambert

(WLA)

and

Pfizer

(PFE) - Get Report

over the blockbuster cholesterol drug, Lipitor. Pfizer filed suit against Warner last month, saying the company broke the terms of a standstill provision in their Lipitor marketing agreement. Warner retaliated against Pfizer by moving to end their agreement to jointly market Lipitor by filing a countersuit in the Delaware court.

Offerings and stock actions

Templeton Dragon Fund

(TDF) - Get Report

, a closed-end management investment company, said it would extend the fund's open-market share repurchases on Japan's

Osaka Securities Exchange.

Miscellany

Gilead Sciences

(GILD) - Get Report

announced the termination of its U.S. development program for adefovir dipivoxil for HIV, after federal regulators turned down a request for accelerated approval early last month.